CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Ten Virtual Fundraising Ideas to Make a Difference from Your Own Home

    Ten fun ideas to take your fundraiser virtual and still support cancer immunotherapy research while safe at…

    March 20, 2020| Cierra Howard
  • A Special Message from the Cancer Research Institute

    CRI has taken steps to ensure the health and safety of our staff and community, and continue…

    March 18, 2020| Jill O'Donnell-Tormey, PhD
  • Isolde Arzt’s Immunotherapy Story: Raising Awareness of Melanoma in Mexico

    Melanoma survivor Isolde Arzt shares her path from cancer patient to patient advocate in Mexico.

    March 18, 2020| Sofia Balog
  • Isolde Arzt: Mi historia con la inmunoterapia y una misión Concientizar sobre Melanoma en México

    Isolde Arzt, sobreviviente de melanoma, comparte su camino de paciente con cáncer a defensora de pacientes en…

    March 18, 2020| CRI Staff
  • Drew G

    Drew Griffin’s Immunotherapy Story

    Colorectal Cancer |  Diagnosed 2012 Be the change you seek in the world. Drew’s Story In October 2012,…
    March 17, 2020| CRI Staff
  • Colorectal Cancer Awareness Month: 2020 Immunotherapy Research Update

    Microsatellite instability, Lynch syndrome, and how we’re working toward a future immune to colorectal cancer.

    March 17, 2020| CRI Staff
  • Kidney Cancer Awareness Month: 2020 Immunotherapy Research Update

    Exciting immunotherapy combinations, lifesaving clinical trials, and how we’re working toward a future immune to kidney cancer.

    March 12, 2020| CRI Staff
  • Multiple Myeloma Awareness Month: 2020 Immunotherapy Research Update

    New FDA approvals, brilliant researchers, and how we’re working toward a future immune to multiple myeloma.

    March 10, 2020| CRI Staff
  • International HPV Awareness Day and the Importance of Immunotherapy

    Immunotherapy is crucial to efforts to prevent HPV infection and treat patients with HPV-associated cancers.

    March 4, 2020| Arthur N. Brodsky, PhD
Previous Page
1 … 37 38 39 40 41 … 92
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute